PHATHOM PHARMACEUTICALS INC's ticker is PHAT and the CUSIP is 71722W107. A total of 112 filers reported holding PHATHOM PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.31 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $35,454,604 | -25.7% | 3,418,959 | +2.6% | 0.01% | -23.1% |
| Q2 2023 | $47,716,202 | +206.3% | 3,332,137 | +52.7% | 0.01% | +225.0% |
| Q1 2023 | $15,577,139 | -37.1% | 2,181,672 | -1.2% | 0.00% | -42.9% |
| Q4 2022 | $24,769,821 | +8.1% | 2,207,649 | +6.8% | 0.01% | 0.0% |
| Q3 2022 | $22,912,000 | +32.6% | 2,067,868 | +1.0% | 0.01% | +40.0% |
| Q2 2022 | $17,276,000 | -38.1% | 2,046,806 | -0.1% | 0.01% | -28.6% |
| Q1 2022 | $27,897,000 | -31.4% | 2,049,759 | -0.9% | 0.01% | -30.0% |
| Q4 2021 | $40,666,000 | -36.5% | 2,067,356 | +3.6% | 0.01% | -37.5% |
| Q3 2021 | $64,072,000 | -6.4% | 1,996,016 | -1.3% | 0.02% | -5.9% |
| Q2 2021 | $68,424,000 | -10.2% | 2,021,400 | -0.4% | 0.02% | -15.0% |
| Q1 2021 | $76,208,000 | +11.7% | 2,028,931 | -1.2% | 0.02% | 0.0% |
| Q4 2020 | $68,248,000 | -10.5% | 2,054,438 | -1.2% | 0.02% | -23.1% |
| Q3 2020 | $76,280,000 | +10.6% | 2,080,187 | -0.7% | 0.03% | +4.0% |
| Q2 2020 | $68,960,000 | +28.7% | 2,095,443 | +1.0% | 0.02% | +8.7% |
| Q1 2020 | $53,594,000 | -18.1% | 2,075,685 | -1.3% | 0.02% | +15.0% |
| Q4 2019 | $65,466,000 | – | 2,102,303 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Medicxi Ventures Management (Jersey) Ltd | 2,067,861 | $40,675,000 | 10.18% |
| FRAZIER MANAGEMENT LLC | 5,827,415 | $114,625,000 | 8.82% |
| Abingworth LLP | 1,203,135 | $23,606,000 | 5.72% |
| RA Capital Management | 3,115,008 | $61,272,000 | 1.08% |
| Avidity Partners Management LP | 1,896,000 | $37,294,000 | 0.79% |
| StepStone Group LP | 422,085 | $8,302,000 | 0.47% |
| Summit Rock Advisors, LP | 34,100 | $671,000 | 0.40% |
| Parkman Healthcare Partners LLC | 77,481 | $1,524,000 | 0.34% |
| Rhenman & Partners Asset Management AB | 186,210 | $3,624,000 | 0.24% |
| Ikarian Capital, LLC | 74,560 | $1,467,000 | 0.22% |